GeneBioTech Co. Ltd (086060) — Free Cash Flow Generation Index
GeneBioTech Co. Ltd (086060) has a Free Cash Flow Generation Index of 0.95x as of September 2025. Free cash flow of ₩3.68 Billion represents 1% of operating cash flow (₩3.87 Billion). See working capital position of GeneBioTech Co. Ltd to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
GeneBioTech Co. Ltd Free Cash Flow Generation Index (2009–2023)
Historical FCF Generation Index trend for GeneBioTech Co. Ltd across 11 annual periods. Explore how well can GeneBioTech Co. Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for GeneBioTech Co. Ltd (2009–2023)
Year-by-year Free Cash Flow Generation Index for GeneBioTech Co. Ltd. For the full company profile including market capitalisation, see GeneBioTech Co. Ltd (086060) market capitalisation.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.90x | ₩6.60 Billion | ₩7.37 Billion | ₩766.93 Million | ▲ +217.8% |
| 2020 | -0.76x | ₩-1.90 Billion | ₩2.49 Billion | ₩4.39 Billion | ▼ -169.5% |
| 2018 | 1.09x | ₩6.51 Billion | ₩5.96 Billion | ₩558.47 Million | ▼ -44.7% |
| 2017 | 1.98x | ₩2.24 Billion | ₩1.13 Billion | ₩1.11 Billion | ▲ +59.0% |
| 2016 | 1.24x | ₩6.61 Billion | ₩5.31 Billion | ₩1.30 Billion | ▼ -8.3% |
| 2015 | 1.36x | ₩3.53 Billion | ₩2.61 Billion | ₩927.06 Million | ▲ +9.6% |
| 2014 | 1.24x | ₩2.67 Billion | ₩2.15 Billion | ₩510.55 Million | ▼ -0.6% |
| 2013 | 1.24x | ₩2.96 Billion | ₩2.38 Billion | ₩582.01 Million | ▼ -37.6% |
| 2011 | 1.99x | ₩5.04 Billion | ₩2.53 Billion | ₩2.51 Billion | ▲ +25.0% |
| 2010 | 1.60x | ₩1.86 Billion | ₩1.17 Billion | ₩693.45 Million | ▲ +46.9% |
| 2009 | 1.09x | ₩2.91 Billion | ₩2.68 Billion | ₩229.99 Million | — |